Last Updated: 3 February 2025

Affineon Health has successfully secured $5 million in an oversubscribed seed funding round, reinforcing its mission to simplify physician workflows and cut down on administrative tasks. The round was led by GPG Ventures, with participation from AI Fund and several new investors.
With this latest investment, Affineon’s total funding reaches $6 million.
Leading investors in this round include Deepwater, Benhamou Global Ventures (BGV), Headwater Ventures, and Signal Peak Ventures, demonstrating strong confidence in Affineon's AI-driven solutions for healthcare.
Doctors and healthcare professionals spend a significant portion of their time managing administrative tasks instead of focusing on patient care. Affineon’s AI-powered inbox automation aims to alleviate this burden by streamlining processes like lab results handling, prescription renewals, and patient communication.
"We're empowering healthcare providers by automating tedious tasks so they can spend more time on patient care and less on administrative work. This oversubscribed round underscores how important solving this problem is and positions Affineon to scale our AI inbox to improve even more lives."
David Norris, Co-Founder and CEO of Affineon Health
With an 80% reduction in inbox volume, Affineon allows providers to reclaim more than five hours per week, helping them work more efficiently and enhance patient experiences.
Affineon plans to use the new capital to accelerate product development and strengthen market expansion efforts. The company will continue enhancing its AI-powered inbox with better EHR (electronic health record) integration, improving response times, and expanding its range of automated workflows.
Additionally, Affineon is looking to broaden its reach, targeting major healthcare systems, physician groups, and telehealth providers. Scaling operations to meet increasing demand is a primary goal, ensuring more healthcare professionals can benefit from AI-powered efficiency.
Affineon Health was founded to redefine efficiency in healthcare and combat physician burnout. The company was co-founded by David Norris, who brings extensive expertise in AI and healthcare technology.
Affineon’s core technology integrates seamlessly with electronic health record (EHR) systems, making it easy for providers to adopt AI without disrupting their current workflows.
What sets Affineon apart is its clinician-first approach—rather than replacing human judgment, its AI assists physicians in making faster, more informed decisions, allowing them to focus on delivering high-quality patient care.
Affineon’s momentum is driven by support from leading investors, each bringing deep expertise in healthcare and technology innovation: